Dominy, J., Bai, J., Koch, C., Zaman Khan, M., Khalid, S., Chung, J. H., Panditrao, M., Liu, L., Zhang, Q., Jahanzaib, M., Mian, M. R., Liaqat, M. B., Raza, S. S., Sultana, R., Jalal, A., Saeed, M. H., Abbas, S., Memon, F. R., Ishaq, M., … Saleheen, D. (2025). Human CD33 deficiency is associated with mild alteration of circulating white blood cell counts. PLOS Genetics, 21(3), e1011600. https://doi.org/10.1371/journal.pgen.1011600

Modi, D., Chowdhury, S. R., Mahamad, S., Modi, H., Cines, D., Neunert, C., Al-Samkari, H., Cooper, N., Moulis, G., Cunningham-Rundles, C., Liebman, H., Bussel, J. B., Breakey, V. R., Nazy, I., & Arnold, D. M. (2024). Primary Versus Secondary Immune Thrombocytopenia (ITP): A Meeting Report from the 2023 McMaster ITP Summit. Thrombosis and Haemostasis. CLOCKSS. https://doi.org/10.1055/a-2508-1112

Neunert, C. E., & Lambert, M. P. (2024). Lightening the load for paediatric ITP: The importance of health‐related quality of life. British Journal of Haematology. Portico. https://doi.org/10.1111/bjh.19719

Akpan, I. J., Bogyo, K., Leeman-Neill, R. J., Wattacheril, J., & Francis, R. O. (2024). Congenital dyserythropoietic anemia type II and ineffective erythropoiesis: challenges in diagnosis and management. Frontiers in Hematology, 3. https://doi.org/10.3389/frhem.2024.1389820

Schaefer, F., Al-Dakkak, I., Saval, N., Cohen, D., Greenbaum, L. A., & Ariceta, G. (2024). #243 Characteristics and safety in patients with atypical haemolytic uraemic syndrome switching to ravulizumab from eculizumab: a global registry analysis. Nephrology Dialysis Transplantation, 39(Supplement_1). https://doi.org/10.1093/ndt/gfae069.011

Jash, A., Pridmore, T., Collins, J. B., Hay, A. M., Hudson, K. E., Luckey, C. J., & Zimring, J. C. (2024). Complement C3 and marginal zone B cells promote IgG-mediated enhancement of RBC alloimmunization in mice. Journal of Clinical Investigation, 134(8). https://doi.org/10.1172/jci167665

Kuter, D. J., Cataland, S. R., Broome, C. M., & Neunert, C. (2024). The latest insights into rare blood disorders: Diagnosis and treatment strategies. American Journal of Hematology. Portico. https://doi.org/10.1002/ajh.27285

Verweij, E., Tura, A. K., Gure, T., Pyuza, J., Mchome, B., Kawaza, K., Moons, P., de Winter, D., van’t Oever, R., Spitalnik, S., van der Schoot, C. E., & van den Akker, T. (2024). Monoclonal RhD prophylaxis: high time to evaluate efficacy. The Lancet, 403(10429), 806–807. https://doi.org/10.1016/s0140-6736(23)01888-3

Anastasiadi, A. T., Arvaniti, V.-Z., Hudson, K. E., Kriebardis, A. G., Stathopoulos, C., D’Alessandro, A., Spitalnik, S. L., & Tzounakas, V. L. (2024). Exploring unconventional attributes of red blood cells and their potential applications in biomedicine. Protein & Cell, 15(5), 315–330. https://doi.org/10.1093/procel/pwae001

Vander Haar, E., Abshier Ware, C., Allen, G., Armstrong, R., Black, D., Bombara, M., Dhanraj, D., Lawrence, L., Miller, R., Nanda, S., Paidas, M. J., Patki, K. C., Sitras, V., Skupski, D., Swarup, M., Thorp, J., Tiller, H., Verweij, J., & Bussel, J. B. (2023). Identifying Pregnancies at Higher Risk for HPA-1a Alloimmunization and Fetal/Neonatal Alloimmune Thrombocytopenia (FNAIT): An International, Prospective, Natural History Study. Blood, 142(Supplement 1), 1224–1224. https://doi.org/10.1182/blood-2023-177657

Zorn, E. (2023). ABO Antibody Development, a New Look at a Very Old Question. Transplantation, 107(11), 2311–2312. https://doi.org/10.1097/tp.0000000000004659

Thomas, T. A., Qiu, A., Kim, C. Y., Gordy, D. E., Miller, A., Tredicine, M., Dzieciatkowska, M., Dei Zotti, F., Hod, E. A., D’Alessandro, A., Zimring, J. C., Spitalnik, S. L., & Hudson, K. E. (2023). Reticulocytes in donor blood units enhance red blood cell alloimmunization. Haematologica, 108(10), 2639–2651. https://doi.org/10.3324/haematol.2023.282815

Stotler, B., Ding, J., Montemayor‐Garcia, C., Spitalnik, S., & Mendez, J. (2023). P‐TS‐72 | Regional and Institutional Variation in Managing Rh Disease in Mexico. Transfusion, 63(S5). Portico. https://doi.org/10.1111/trf.409_17554

Zotti, F. D., Qiu, A., Miller, A., Zimring, J., & Hudson, K. (2023). PL2‐AM23‐SN‐30 | Apyrase Reduces Severity of Autoimmune Hemolytic Anemia (AIHA) Secondary to Checkpoint Inhibitors in a Mouse Model. Transfusion, 63(S5). Portico. https://doi.org/10.1111/trf.1_17554

Jajosky, R. P., Patel, S. R., Wu, S.-C., Patel, K. R., Covington, M. L., Vallecillo-Zúniga, M. L., Ayona, D., Bennett, A., Luckey, C. J., Hudson, K. E., Hendrickson, J. E., Eisenbarth, S. C., Josephson, C. D., Zerra, P. E., Stowell, S. R., & Arthur, C. M. (2023). Prior Immunization to an Intracellular Antigen Enhances Subsequent Red Blood Cell Alloimmunization in Mice. Blood. https://doi.org/10.1182/blood.2022016588

Ramsey, G., Park, Y. A., Eder, A. F., Bobr, A., Karafin, M. S., Karp, J. K., King, K. E., Pagano, M. B., Schwartz, J., Szczepiorkowski, Z. M., Souers, R. J., Thomas, L., & Delaney, M. (2022). Obstetric and Newborn Weak D-Phenotype RBC Testing and Rh Immune Globulin Management Recommendations: Lessons From a Blinded Specimen-Testing Survey of 81 Transfusion Services. Archives of Pathology & Laboratory Medicine, 147(1), 71–78. https://doi.org/10.5858/arpa.2021-0250-cp

Thomas, T., Qiu, A., Kim, C. Y., Gordy, D. E., Miller, A., Tredicine, M., Stone, E., Dzieciatkowska, M., Hod, E. A., D’Alessandro, A., Spitalnik, S. L., Zimring, J. C., Akpan, I. J., Luckey, C. J., & Hudson, K. E. (2022). Reticulocytes Are an Unappreciated Risk Factor for RBC Alloimmunization at the Donor and Recipient Levels. Blood, 140(Supplement 1), 75–76. https://doi.org/10.1182/blood-2022-169746

Balamurugan, M. A., Desiraju, S., Wojczyk, B. S., Namachivayam, K., Chung, Y., Guzman, P., & Krishnan, M. (2022). RBC Transfusion to Severe Anemic Murine Neonates Leads to Systemic Inflammation. Blood, 140(Supplement 1), 5702–5703. https://doi.org/10.1182/blood-2022-159574

Jajosky, R. P., Allen, J. W., Zerra, P. E., Maier, C. L., Chonat, S., Luckey, C. J., Roback, J. D., Fasano, R. M., Josephson, C. D., Manis, J. P., Chai, L., Hendrickson, J. E., Hudson, K. E., Arthur, C. M., & Stowell, S. R. (2022). Antibody-Mediated Antigen Loss Can Switch an Augmented Immune Response to Antibody-Mediated Immunosuppression. Blood, 140(Supplement 1), 73–74. https://doi.org/10.1182/blood-2022-170081

Qiu, A., Miller, A., Zotti, F. D., Santhanakrishnan, M., Hendrickson, J. E., Tredicine, M., Stowell, S. R., Luckey, C. J., Zimring, J. C., & Hudson, K. E. (2022). FcγRIV is required for IgG2c mediated enhancement of RBC alloimmunization. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.972723

Kudose, S., Jagannathan, G., Santoriello, D., Sekulic, M., Batal, I., Stokes, M. B., D’Agati, V. D., & Markowitz, G. S. (2022). Validation Study on the Utility of Immunoglobulin Heavy/Light Chain Immunofluorescence in Kidney Biopsies With Potential Monoclonal Gammopathy of Renal Significance Lesions. Kidney International Reports, 7(5), 1119–1122. https://doi.org/10.1016/j.ekir.2022.01.1071

Hillier, K., Rothman, J. A., Klaassen, R. J., Neunert, C., Rose, M. J., Grace, R. F., & Lambert, M. P. (2022). SARS‐CoV‐2 vaccination in pediatric patients with immune thrombocytopenia. Pediatric Blood & Cancer, 69(7). Portico. https://doi.org/10.1002/pbc.29760

Kanter, J., Walters, M. C., Krishnamurti, L., Mapara, M. Y., Kwiatkowski, J. L., Rifkin-Zenenberg, S., Aygun, B., Kasow, K. A., Pierciey, F. J., Bonner, M., Miller, A., Zhang, X., Lynch, J., Kim, D., Ribeil, J.-A., Asmal, M., Goyal, S., Thompson, A. A., & Tisdale, J. F. (2022). Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease. New England Journal of Medicine, 386(7), 617–628. https://doi.org/10.1056/nejmoa2117175

Soldatenko, A., Hoyt, L. R., Xu, L., Calabro, S., Lewis, S. M., Gallman, A. E., Hudson, K. E., Stowell, S. R., Luckey, C. J., Zimring, J. C., Liu, D., Santhanakrishnan, M., Hendrickson, J. E., & Eisenbarth, S. C. (2022). Innate and Adaptive Immunity to Transfused Allogeneic RBCs in Mice Requires MyD88. The Journal of Immunology, 208(4), 991–997. https://doi.org/10.4049/jimmunol.2100784